[
  {
    "ts": null,
    "headline": "TECH Q2 Deep Dive: Margin Pressures and Portfolio Shifts Amid Market Uncertainty",
    "summary": "Life sciences company Bio-Techne (NASDAQ:TECH) announced better-than-expected revenue in Q2 CY2025, with sales up 3.5% year on year to $317 million. Its non-GAAP profit of $0.53 per share was 6.1% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=5003837bdc3b12174026ba606c1bfdac751c31698c83ada1116e1501671e989e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754983067,
      "headline": "TECH Q2 Deep Dive: Margin Pressures and Portfolio Shifts Amid Market Uncertainty",
      "id": 136316639,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Life sciences company Bio-Techne (NASDAQ:TECH) announced better-than-expected revenue in Q2 CY2025, with sales up 3.5% year on year to $317 million. Its non-GAAP profit of $0.53 per share was 6.1% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=5003837bdc3b12174026ba606c1bfdac751c31698c83ada1116e1501671e989e"
    }
  }
]